Literature DB >> 21993919

LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications.

Meiling Yan1, Jawahar L Mehta, Weifang Zhang, Changping Hu.   

Abstract

Diabetes mellitus is a common metabolic disease characterized by a state of oxidative stress, inflammation and endothelial dysfunction. This malady can lead to a number of complications such as ischemic heart disease, nephropathy, neuropathy, retinopathy and impaired wound healing. The etiology of diabetic complications is multifactorial, and is closely associated with oxidative stress and inflammation. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a receptor for oxidized low density lipoprotein (ox-LDL), plays critical roles in multiple signal transduction pathways and is involved in the process of oxidative stress and inflammation. Recent studies provide important insights into the roles of LOX-1 in the development and progression of diabetic vasculopathy which is the underlying mechanism of diabetic complications. In this review, we summarize mechanistic studies, mainly related to LOX-1, on the development and progression of diabetes mellitus and its cardiovascular complications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993919     DOI: 10.1007/s10557-011-6342-4

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  22 in total

1.  LOX-1-Targeted Iron Oxide Nanoparticles Detect Early Diabetic Nephropathy in db/db Mice.

Authors:  Bing Luo; Song Wen; Yu-Chen Chen; Ying Cui; Fa-Bao Gao; Yu-Yu Yao; Sheng-Hong Ju; Gao-Jun Teng
Journal:  Mol Imaging Biol       Date:  2015-10       Impact factor: 3.488

2.  Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.

Authors:  Oguzhan Ozturk; Yasar Colak; Ebubekir Senates; Yusuf Yilmaz; Celal Ulasoglu; Levent Doganay; Seyma Ozkanli; Yasemin Musteri Oltulu; Ender Coskunpinar; Ilyas Tuncer
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

3.  Serum sLOX-1 Levels Are Correlated with the Presence and Severity of Obstructive Sleep Apnea.

Authors:  Chun-Yan Xu; Da-Ju Li; Chun-Ling Wu; Han-Jian Lou; Hong-Wei Jiang; Guo-Qiang Ding
Journal:  Genet Test Mol Biomarkers       Date:  2015-03-31

Review 4.  Mechanisms of Synergistic Interactions of Diabetes and Hypertension in Chronic Kidney Disease: Role of Mitochondrial Dysfunction and ER Stress.

Authors:  Zhen Wang; Jussara M do Carmo; Alexandre A da Silva; Yiling Fu; John E Hall
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

5.  Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.

Authors:  Yungen Jiao; Feng Hu; Zhengang Zhang; Kaizheng Gong; Xiaoning Sun; Aihua Li; Naifeng Liu
Journal:  Clin Drug Investig       Date:  2015-12       Impact factor: 2.859

6.  Effect of rosuvastatin dose-loading on serum sLox-1, hs-CRP, and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI).

Authors:  Yungen Jiao; Feng Hu; Zhengang Zhang; Kaizheng Gong; Xiaoning Sun; Aihua Li; Naifeng Liu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Therapeutic Effects of Adipose Stem Cells from Diabetic Mice for the Treatment of Type 2 Diabetes.

Authors:  Mengmeng Wang; Lili Song; Charlie Strange; Xiao Dong; Hongjun Wang
Journal:  Mol Ther       Date:  2018-06-19       Impact factor: 11.454

8.  Elevation of serum oxLDL/β2-GPI complexes was correlated with diabetic microvascular complications in Type 2 diabetes mellitus patients.

Authors:  Lianzhi Xie; Hui Lin; Caihong Wang
Journal:  J Clin Lab Anal       Date:  2018-09-26       Impact factor: 2.352

9.  Hyperglycaemia exacerbates choroidal neovascularisation in mice via the oxidative stress-induced activation of STAT3 signalling in RPE cells.

Authors:  Xia Li; Yan Cai; Yu-Sheng Wang; Yuan-Yuan Shi; Wei Hou; Chun-Sheng Xu; Hai-Yan Wang; Zi Ye; Li-Bo Yao; Jian Zhang
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

10.  Comparison of ox-LDL Levels in Diabetic Patients with Normo-, Micro-, and Macroalbuminuria with Their First Degree Relatives and the Healthy Control Group.

Authors:  Parisa Behzadi; Firouzeh Torabi; Massoud Amini; Ashraf Aminorroaya
Journal:  Int J Endocrinol       Date:  2012-11-01       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.